Trevena Announces Poster Presentations of TRV045 Nonclinical Epilepsy Data, and OLINVYK Clinical Neurocognitive and GI Data, at Recent Medical Meetings
TRV045 data reflected reduced seizure burden in nonclinical models of acute epilepsy presented at American College of Neuropsychopharmacology (ACNP) Annual Meeting
Related news for (TRVN)
- Trevena Publicizes TRV045 Preclinical Data
- Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise
- Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
- Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting